Development of a Risk Stratification Model for Histologic Transformation of Indolent B-Cell Lymphomas Using Ultrasound Imaging

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400091448

Enrollment

Unknown

Registered

2024-10-29

Start date

2024-11-01

Completion date

Unknown

Last updated

2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Indolent B-cell lymphomas

Interventions

Gold Standard:Pathology results of the biopsy site

Index test:Multi-model ultrasound examinations

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients with B-cell non-Hodgkin lymphoma who underwent ultrasound examinations and ultrasound-guided core-needle biopsy of lymph nodes at Ruijin Hospital from June 2022 to December 2028

Exclusion criteria

Exclusion criteria: 1: Most clinical data are missing; 2: The pathology results confirm the presence of tuberculosis or other concurrent malignant tumors; 3: Although there is clear evidence of B-cell non-Hodgkin's lymphoma, a clear pathological classification has not been obtained; 4: The follow-up time is less than 6 months

Design outcomes

Primary

Measure	Time frame
Multi-modal ultrasound images and radiomic features;Specificity;Sensitivity;Area Under the ROC Curve, AUC;	—

Countries

China

Contacts

Public ContactRonghui Wang

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

wrh12566@rjh.com.cn+86 135 0030 5284

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026